We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Provexis Plc | LSE:PXS | London | Ordinary Share | GB00B0923P27 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.65 | 0.60 | 0.70 | - | 199,198 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Food Preparations, Nec | 390k | -385k | -0.0002 | -32.50 | 14.42M |
Date | Subject | Author | Discuss |
---|---|---|---|
04/10/2017 13:21 | I have bought back into AGL recently showing a few % profit on this run | senor_sensible | |
04/10/2017 13:18 | SS; it means SO much more when repeated. :) FWIW, I agree. BWT shame about AGL. Thankfully sold in the early 50s. It's one of those admittedly unusual shares that I've traded profitably. Bit of a divergence at the mo. so might look more closely; not been following fundamentals. Thoughts? | librag | |
04/10/2017 13:12 | Libra, lol..... it's not in breakout territory but pegged as weak buy and hold. Think this is the new floor, or here abouts :-) | senor_sensible | |
04/10/2017 12:54 | Libra, lol..... it's not in breakout territory but pegged as weak buy and hold. Think this is the new floor, or here abouts :-) | senor_sensible | |
04/10/2017 11:02 | SS; you're a very nice person but really? There's a nice target around 1.4p but TBH the TA is wishful thinking at this point. What am I missing? Fundamentals are looking rather better though. GL. | librag | |
04/10/2017 07:28 | SP is well supported at this price, and looks like a buy signal is getting stronger..... Just saying | senor_sensible | |
04/10/2017 01:24 | From the AGM:- Note:- still stating "First launch envisaged in second half of 2017: So, hopefully we should be getting confirmation of the launch of new Fruitflow products in China soon. "Fruitflow®. The Company also confirmed separately that Provexis and DSM are working with BY-HEALTH to support the planned launch of some Fruitflow® based products in the Chinese market, with the first launch envisaged in the second half of 2017". "BY-HEALTH is a substantial Chinese listed dietary supplement business which is currently valued in excess of £2bn." | wheelds | |
04/10/2017 01:10 | Health span magazine, Love your heart naturally this October page 10), highlights the extra benefits of Fruitflow, under Heart Health:- I expect our 50 plus Fruitflow products around the world will also be mentioning this new health factor too, which should increase trade. IMHO Advert says:- "Contributes to normal blood pressure." "A healthy blood pressure plays a key role in the function of a healthy circulation system. | wheelds | |
30/9/2017 01:16 | "Results from the pilot study indicated that a 150mg dose of Fruitflow® in powder format significantly lowered the average 24-hour systolic blood pressure compared to placebo. When the monitoring time was split into waking and sleeping periods, both systolic and diastolic blood pressure were significantly lower after 150mg Fruitflow® treatment than after placebo treatment during the waking period; systolic pressure was also significantly lower during the sleeping period. Platelet response to ADP agonist was significantly reduced 24 hours after consumption of Fruitflow®. The supplements were given in a single dose at the start of the 24-hour monitoring period; further work is likely to be required to understand the optimal dosage pattern." "Raised blood pressure is estimated to cause more than 7 million premature deaths throughout the world each year, and 4.5% of the disease burden. Treating raised blood pressure by way of achieving systolic blood pressure < 140 and diastolic blood pressure < 80 has been associated with a 35-40% reduction in the risk of stroke and at least a 16% reduction in the risk of heart attack (WHO 2007). These pilot study results therefore show that Fruitflow® may have clinically relevant effects in blood pressure control." | wheelds | |
28/9/2017 18:37 | Trolls + stupid = weird. You already contaminate the blue board. Why not give this one a break? | librag | |
28/9/2017 17:21 | This board is getting weirder and weirder by the day. | lafin | |
28/9/2017 16:08 | Article does not mention Fruitflow products yet but I am sure By-Health, the Chinese company will be selling our new Fruitflow products into this growing demand in China.IMHO "Demand for functional food and drink has shot up in APAC, particularly in China, where 80% of the population claims to want to make their diets more healthy. And four key health concerns are driving sales." | wheelds | |
28/9/2017 11:32 | Not all tomatoes are the same. Can't be bothered finding links etc so bla bla bla bla bla and my conclusion is that you can't be sure you will be getting enough or too much of whatever the active molecules are from STE. | lafin | |
27/9/2017 20:51 | In fact one of (the very few) non-nutjobs on iii posted a link to Zaax, one of our licenced products. The report succinctly relates STE ingestion to various pathologies thus saving considerable effort in research, which I would have found challenging tbh. hxxp://www.researchg Fwiw with some positions over the years I have felt strong feelings on being on the cusp of success in investment decisions namely Tcg, Tni, Lloy, Bp, ezy etc etc but still feel equivocal re Pxs; they are prone to fundraising, the mcap is still divergent with the fundamentals to the wrong side. Rkh is primed to explode to the upside along with Bor and possibly Bzm. Rarely over ten years of investing have I felt that my portfolio is positioned for massive profits in zero tax wrappers. | gunsofmarscapone | |
27/9/2017 19:46 | Just going to have one with a drop of rum :-) | ron64 | |
27/9/2017 12:29 | Healthy coke anyone? :) | librag | |
27/9/2017 11:42 | Got one too and you can win this thing | lafin | |
27/9/2017 11:07 | interesting email from Provexis today, sharing details of cardio vascular health with links to Dr Hilary video and testimonials from users - Including high blood pressure :-) | senor_sensible | |
27/9/2017 07:38 | Another step in the right direction, company are sufficiently financed unless they enter into JV or acquisition which I would probably support financing further. Going to be some resistance on the way up but no reason this couldn't be trading above 1p to 1.5p in new year. | senor_sensible | |
27/9/2017 00:48 | Pivotal news, what absolutely stellar clinical trial results demonstrating a clear reduction of risk to critical diseases yet with ZERO side effects. This is the key point. My next research item is to correlate blood pressure and platelet aggregation to actual pathology. Fund raising risk to company owners still exists but whether we are now at the inflexion point is an open question; how will the media amplify this! If it does go viral then our valuation could go into space, not exactly rational or indeed correlating with fundamentals but useful nevertheless. Gla everyone, GoM in modest profit thanks to <0.4 buys but yes, bought more today <0.6 lomg term hold. | gunsofmarscapone |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions